ADT	Androgen deprivation therapy
AR	Androgen receptor
BPH	Benign prostatic hyperplasia
CRPC	Castration-resistant prostate cancer
CTCs	Circulating tumor cells
ECM	Extracellular matrix
EMT	Epithelial-mesenchymal-transition
GPCRs	G-protein coupled receptors
MET	Mesenchymal-epithelial-transition
MMP	Metalloproteinases
NE	Neuroendocrine
OPG	Osteoprotegerin
PINs	Prostatic intraepithelial neoplasia
RANKL	Receptor activator of nuclear factor kappa B ligand
TGFβ	Transforming growth factor beta
TNF	Tumor necrosis factor
VEGF	Vascular endothelial growth factor